Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes with Several Cardiovascular Risk Factors

Circulation Research

Volumn 118, Issue 1, 2016, Pages 83-94

  Leblanc, Marissa ^a   Zuber, Verena ^b   Andreassen, Bettina Kulle ^a   Witoelar, Aree ^b   Zeng, Lingyao ^c,d   Bettella, Francesco ^b   Wang, Yunpeng ^b,e,f   McEvoy, Linda K ^e   Thompson, Wesley K ^e,g   Schork, Andrew J ^e   Reppe, Sjur ^a,b,h   Barrett Connor, Elizabeth ^e   Ligthart, Symen ⁱ   Dehghan, Abbas ⁱ   Gautvik, Kaare M ^a,h   Nelson, Christopher P ^j,k   Schunkert, Heribert ^c,d   Samani, Nilesh J ^j,k   Ridker, Paul M ^l   Chasman, Daniel I ^l   Aukrust, Pål ^a   Djurovic, Srdjan ^b   Frigessi, Arnoldo ^a   Desikan, Rahul S ^a,e,m   Dale, Anders M ^e,f,g   Andreassen, Ole A ^b,e   more..

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Deutsches Zentrum für Herz Kreislauf Forschung Partner Site   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h LOVISENBERG DIAKONALE HOSPITAL   (Norway)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF LEICESTER   (United Kingdom)

^k GLENFIELD HOSPITAL   (United Kingdom)

^l HARVARD MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

coronary artery disease; coronary heart disease; genetic pleiotropy; genome wide association study; lipids; molecular epidemiology; myocardial infarction; Women's Genome Health Study

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; FEMALE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR;

CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84954561386     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.306629     Document Type: Article

References (53)

1. Peden JF, Farrall M. Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum Mol Genet. 2011;20:R198-R205. doi: 10.1093/hmg/ddr384.
2. CAD Consortium, Deloukas P, Kanoni S, Willenborg C, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25-33. doi: 10.1038/ng.2480.
3. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 2010;11:446-450. doi: 10.1038/nrg2809.
4. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753 doi: 10.1038/nature08494.
5. Li C, Yang C, Gelernter J, Zhao H. Improving genetic risk prediction by leveraging pleiotropy. Hum Genet. 2014;133:639-650. doi: 10.1007/s00439-013-1401-5.
6. Andreassen OA, Thompson WK, Schork AJ, et al; Psychiatric Genomics Consortium (PGC); Bipolar Disorder and Schizophrenia Working Groups. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2013;9:e1003455. doi: 10.1371/journal.pgen.1003455.
7. Yang J, Manolio TA, Pasquale LR, et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet. 2011;43:519-525. doi: 10.1038/ng.823.
8. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med. 2000;342:1-8. doi: 10.1056/NEJM200001063420101.
9. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383:970-983. doi: 10.1016/S0140-6736(13)61836-X.
10. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666-678. doi: 10.1016/S0140-6736(06)69251-9.
11. Cushman WC, Evans GW, Byington RP, et al; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585. doi: 10.1056/NEJMoa1001286.
12. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111:3481-3488. doi: 10.1161/CIRCULATIONAHA.105.537878.
13. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007;370:591-603. doi: 10.1016/S0140-6736(07)61299-9.
14. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428. doi: 10.1016/S0140-6736(05)66378-7.
15. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon Circulation. 1999;100:96-102.
16. Coffman TM. Under pressure: the search for the essential mechanisms of hypertension. Nat Med. 2011;17:1402-1409. doi: 10.1038/nm.2541.
17. Wagner GP, Zhang J. The pleiotropic structure of the genotype-phenotype map: the evolvability of complex organisms. Nat Rev Genet. 2011;12:204-213. doi: 10.1038/nrg2949.
18. Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O'Donovan MC, Rujescu D, Werge T, van de Bunt M, Morris AP, McCarthy MI, Roddey JC, McEvoy LK, Desikan RS, Dale AM; International Consortium for Blood Pressure GWAS; Diabetes Genetics Replication and Meta-analysis Consortium; Psychiatric Genomics Consortium Schizophrenia Working Group. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet. 2013;92:197-209. doi: 10.1016/j.ajhg.2013.01.001.
19. Andreassen OA, McEvoy LK, Thompson WK, Wang Y, Reppe S, Schork AJ, Zuber V, Barrett-Connor E, Gautvik K, Aukrust P, Karlsen TH, Djurovic S, Desikan RS, Dale AM; International Consortium for Blood Pressure Genome-Wide Association Studies, Genetic Factors for Osteoporosis Consortium. Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes. Hypertension. 2014;63:819-826. doi: 10.1161/HYPERTENSIONAHA.113.02077.
20. Andreassen OA, Harbo HF, Wang Y, et al; Psychiatric Genomics Consortium (PGC) Bipolar Disorder and Schizophrenia Work Groups; International Multiple Sclerosis Genetics Consortium (IMSGC). Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol Psychiatry. 2015;20:207-214. doi: 10.1038/mp.2013.195.
21. Andreassen OA, Zuber V, Thompson WK, Schork AJ, Bettella F, Djurovic S, Desikan RS, Mills IG, Dale AM; PRACTICAL Consortium; CRUK GWAS. Shared common variants in prostate cancer and blood lipids. Int J Epidemiol. 2014;43:1205-1214. doi: 10.1093/ije/dyu090.
22. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
23. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234. doi: 10.1056/NEJM199807233390404.
24. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-1250. doi: 10.1161/01. CIR.0000140677.20606.0E.
25. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695. doi: 10.1056/NEJMra043430.
26. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713. doi: 10.1038/nature09270.
27. Morris AP, Voight BF, Teslovich TM, et al; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981-990. doi: 10.1038/ng.2383.
28. Dehghan A, Dupuis J, Barbalic M, et al. Meta-analysis of genomewide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123:731-738. doi: 10.1161/CIRCULATIONAHA.110.948570.
29. Speliotes EK, Willer CJ, Berndt SI, et al; MAGIC; Procardis Consortium. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937-948. doi: 10.1038/ng.686.
30. Heid IM, Jackson AU, Randall JC, et al; MAGIC. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet. 2010;42:949-960. doi: 10.1038/ng.685.
31. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-109.
32. Barrett JC, Clayton DG, Concannon P, et al; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41:703-707. doi: 10.1038/ng.381.
33. Voight BF, Kang HM, Ding J, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 2012;8:e1002793. doi: 10.1371/journal.pgen.1002793.
34. Witte JS. Genome-wide association studies and beyond. Annu Rev Public Health. 2010;31:9-20 4 p following 20. doi: 10.1146/annurev. publhealth.012809.103723.
35. Ridker PM, Chasman DI, Zee RY, Parker A, Rose L, Cook NR, Buring JE; Women's Genome Health Study Working Group. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem. 2008;54:249-255. doi: 10.1373/clinchem.2007.099366.
36. Chen L, Storey JD. Relaxed significance criteria for linkage analysis. Genetics. 2006;173:2371-2381. doi: 10.1534/genetics.105.052506.
37. Lin DY, Sullivan PF. Meta-analysis of genome-wide association studies with overlapping subjects. Am J Hum Genet. 2009;85:862-872. doi: 10.1016/j.ajhg.2009.11.001.
38. Zaykin DV, Kozbur DO. P-value based analysis for shared controls design in genome-wide association studies. Genet Epidemiol. 2010;34:725-738. doi: 10.1002/gepi.20536.
39. Westra HJ, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45:1238-1243. doi: 10.1038/ng.2756.
40. Grundberg E, Meduri E, Sandling JK, et al; Multiple Tissue Human Expression Resource Consortium. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am J Hum Genet. 2013;93:876-890. doi: 10.1016/j.ajhg.2013.10.004.
41. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073.
42. Ehret GB. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep. 2010;12:17-25. doi: 10.1007/s11906-009-0086-6.
43. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-753. doi: 10.1161/CIRCULATIONAHA.107.699579.
44. Conroy RM, Pyörälä K, Fitzgerald AP, et al; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.
45. Albert JS, Yerges-Armstrong LM, Horenstein RB, et al. Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. N Engl J Med. 2014;370:2307-2315. doi: 10.1056/NEJMoa1315496.
46. Kristiansson K, Perola M, Tikkanen E, et al. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet. 2012;5:242-249. doi: 10.1161/CIRCGENETICS.111.961482.
47. Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res. 2012;53:1723-1737. doi: 10.1194/jlr.R024794.
48. Qi L, Qi Q, Prudente S, et al. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA. 2013;310:821-828. doi: 10.1001/jama.2013.276305.
49. Do R, Willer CJ, Schmidt EM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45:1345-1352. doi: 10.1038/ng.2795.
50. Andreassen OA, Desikan RS, Wang Y, et al. Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms. PLoS One. 2015;10:e0123057. doi: 10.1371/journal.pone.0123057.
51. Parikh M, Patel K, Soni S, Gandhi T. Liver X receptor: a cardinal target for atherosclerosis and beyond. J Atheroscler Thromb. 2014;21:519-531.
52. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA. 2009;106:9362-9367. doi: 10.1073/pnas.0903103106.
53. Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 2013;14:483-495. doi: 10.1038/nrg3461.